All new patients are evaluated initially by the resident and then presented to the faculty. All gynecologic oncology patients are seen at this facility and the fellow also has his/her Fellow’s Clinic ...

Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and ...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced multiple ...

IMUNON, Inc. announced that data from its Phase 2 OVATION 2 trial, which explores the use of intraperitoneal IMNN-001 combined with chemotherapy for advanced epithelial ovarian cancer, will be ...

Analysis of data from over 1.2 million US patients with gynecologic cancers between 2004 and 2020 revealed a significant shift towards surgical de-escalation, with increased use of minimally invasive ...

We performed a quality improvement study to evaluate our GT processes within gynecologic surgery/medical oncology clinics. All eligible patients with newly diagnosed OC/EC were identified for GT and ...

Susan Bohnenkamp's compassion and empathy create a supportive environment for oncology patients, enhancing their care experience. Her extensive oncology expertise, rooted in continuous education, ...

Gynecologic oncology has shifted towards surgical de-escalation, emphasizing minimally invasive techniques and sentinel lymph node methods to reduce tissue injury while preserving oncologic outcomes.

Neoadjuvant chemotherapy increasingly matches upfront debulking outcomes, reducing extreme surgery risks while highlighting why patients still need access to R0 radical resection.